November 3, 2020 11:16 AM EST
News Briefing

News brief­ing: Gilead sub­mits fil­go­tinib to Eu­ro­pean reg­u­la­tors for UC; GW Phar­ma­ceu­ti­cals launch­es PhI­II tri­al for MS can­di­date made with cannabis ex­tracts

Max Gelman

Senior Editor

Nicole DeFeudis

Editor

Gilead’s fil­go­tinib is get­ting a chance at a new in­di­ca­tion in Eu­rope af­ter the US reg­u­la­tors hand­ed down a CRL a few months ago. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump taps Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, sur­geon gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

ADC biotech Ad­cen­do nabs $135M Se­ries B as it en­ters the clin­ic

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

For CDC, Trump picks Dave Wel­don, a for­mer con­gress­man who pushed for vac­cine in­jury claims

From vac­cines to psy­che­delics, five drug­mak­ers on what could change un­der a Trump ad­min­is­tra­tion

A service from the Financial Times